Prøve GULL - Gratis
India Eyes ₹5,000 Cr Plan To Be Pharma Innovation Hub
Mint Bangalore
|February 27, 2025
While Indian companies have dominated in generic drugs, they are laggards in R&D
India is making a push to move beyond its dominance in generic drugs and establish itself as a hub for pharmaceutical innovation.
The government will invite expressions of interest in March for a ₹5,000 crore funding corpus aimed at accelerating research in drug discovery, medical technology (medtech), and stem cell therapy, with bid submissions expected in April.
The initiative, part of the Promotion of Research & Innovation in Pharma MedTech Sector (PRIP) scheme launched in August 2023 for a five-year period, seeks to boost domestic R&D and reduce India's reliance on imported technology.
"We are planning to float the expression of interest (EOI) very likely early next month to get a sense how companies are coming forward and based on the response, we will invite bids in April," said an official from the department of pharmaceuticals, familiar with the matter.
Denne historien er fra February 27, 2025-utgaven av Mint Bangalore.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Bangalore
Mint Bangalore
Morgan Stanley bets on India stocks
Indian equities are set to reverse their historic underperformance against emerging market peers next year, powered by government policy actions, according to Morgan Stanley.
1 min
November 19, 2025
Mint Bangalore
Data rules to tighten screws on e-comm dark pattern, food apps
The Digital Personal Data Protection Rules, 2025, may force e-commerce, ride-hailing and food delivery apps to rethink the way they design their interfaces.
2 mins
November 19, 2025
Mint Bangalore
Ultraviolette forays into the UK market
Electric two-wheeler maker Ultraviolette on Tuesday announced its entry into the UK market.
1 min
November 19, 2025
Mint Bangalore
SIFs: WHAT YOU MUST KNOW ABOUT THE HIGHER-RISK, HIGHER-REWARD TRADE-OFF
The concept of specialized investment funds (SIFs) was allowed by the Securities and Exchange Board of India (Sebi), in the space between mutual funds meant for the masses and portfolio management schemes and alternative investment funds (PMS/AIFs) meant for the classes.
3 mins
November 19, 2025
Mint Bangalore
CVC, EQT in talks to acquire ValueLabs
cial intelligence (AI) service provider currently has over 7,000 engineers and serves more than 300 enterprise clients, according to its website.
1 min
November 19, 2025
Mint Bangalore
India needs a calibrated approach to Bangladesh
While refuge for Sheikh Hasina is clearly a must, New Delhi's challenge is to secure India's logistical and strategic interests in a country with good reason to stay cooperative with us
2 mins
November 19, 2025
Mint Bangalore
More Retail picks banks for India IPO
More Retail Pvt., the food and grocery chain jointly owned by Amazon.com Inc. and Samara Capital Partners, has picked advisers for an impending initial public offering that could raise about $300 million, according to people familiar with the matter.
1 min
November 19, 2025
Mint Bangalore
Satcom’s real value is inclusion: OneWeb
Bharti Enterprises-backed Eutelsat OneWeb, one of the companies vying to offer satellite internet in India, said on Tuesday that the true economic value of satellite communication (satcom) services didn’t lie in government revenue streams such as licence or spectrum fees, but in the long-term national benefits they would provide.
1 min
November 19, 2025
Mint Bangalore
China's unprecedented investment collapse puzzles economists and threatens growth
China’s collapsing investment is as unprecedented as it is hard to explain.
4 mins
November 19, 2025
Mint Bangalore
Capillary IPO logs robust turnout
The initial share sale of Capillary Technologies India Ltd got subscribed 52.95 times on the final day of subscription on Tuesday.
1 min
November 19, 2025
Listen
Translate
Change font size